BIOPHARM DRUG DISPOS 润色咨询

BIOPHARMACEUTICS & DRUG DISPOSITION

出版年份:1979 年文章数:819 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:6.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1088009, encodeId=a66b10880097d, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088010, encodeId=a2e310880103c, content=摘要一般有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540214, encodeId=e348540214d0, content=太狠了!跌了这么多,以后谁还敢投??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=818641, encodeId=ebe98186416a, content=if:1.394 2011年 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Wed Mar 21 09:21:00 CST 2012, time=2012-03-21, status=1, ipAttribution=)]
    2021-12-29 小动量

    我是写那种格式的摘要比较好?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1088009, encodeId=a66b10880097d, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088010, encodeId=a2e310880103c, content=摘要一般有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540214, encodeId=e348540214d0, content=太狠了!跌了这么多,以后谁还敢投??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=818641, encodeId=ebe98186416a, content=if:1.394 2011年 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Wed Mar 21 09:21:00 CST 2012, time=2012-03-21, status=1, ipAttribution=)]
    2021-12-29 MS54455111222

    摘要一般有什么要求?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1088009, encodeId=a66b10880097d, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088010, encodeId=a2e310880103c, content=摘要一般有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540214, encodeId=e348540214d0, content=太狠了!跌了这么多,以后谁还敢投??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=818641, encodeId=ebe98186416a, content=if:1.394 2011年 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Wed Mar 21 09:21:00 CST 2012, time=2012-03-21, status=1, ipAttribution=)]
    2017-07-18 ding_ying

    太狠了!跌了这么多,以后谁还敢投??

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1088009, encodeId=a66b10880097d, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088010, encodeId=a2e310880103c, content=摘要一般有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540214, encodeId=e348540214d0, content=太狠了!跌了这么多,以后谁还敢投??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ding_ying, createdTime=Tue Jul 18 18:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=818641, encodeId=ebe98186416a, content=if:1.394 2011年 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Wed Mar 21 09:21:00 CST 2012, time=2012-03-21, status=1, ipAttribution=)]
    2012-03-21 ms8928334115937663

    if:1.394 2011年

    0

共6条页码: 1/1页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分